Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Driven by 2 papers. Top paper: “Cost-effectiveness of pembrolizumab for advanced non-small cell lung cancer patients with varying comorbidity burden”.
Lauren Palazzo, Tina R. Watson, Adelle Paquette, Keith Sigel, Juan P. Wisnivesky +2 more
Lauren Palazzo, Adelle Paquette, Andrew Eckel, Francine L. Jacobson, Eduardo Mortani Barbosa +2 more